2020
A Critical Review of Alcohol Administration Guidelines in Laboratory Medication Screening Research: Is It Time to Include Treatment Seekers?
Roberts W, Verplaetse TL, Ramchandani VA, McKee SA. A Critical Review of Alcohol Administration Guidelines in Laboratory Medication Screening Research: Is It Time to Include Treatment Seekers? Alcohol Clinical And Experimental Research 2020, 45: 15-24. PMID: 33190310, PMCID: PMC7855436, DOI: 10.1111/acer.14514.Peer-Reviewed Original ResearchMeSH KeywordsAdrenergic alpha-2 Receptor AgonistsAlcohol DeterrentsAlcohol-Related DisordersClinical Trials as TopicGuanfacineHumansNaltrexonePatient SelectionConceptsHuman laboratory studiesTreatment seekersNontreatment seekersExpensive clinical trialsPatient populationAlcohol administrationClinical trialsMedication effectsClinical conditionsMedication developmentMedicationsHeavy drinkersMedication experimentsLaboratory screeningClinical realityAdministration guidelinesScreening researchDevelopment pipelineLaboratory studiesRiskGuidelinesParticipantsPharmacotherapyPopulationEthical guidelines
2014
Consideration of Sex in Clinical Trials of Transdermal Nicotine Patch: A Systematic Review
Weinberger AH, Smith PH, Kaufman M, McKee SA. Consideration of Sex in Clinical Trials of Transdermal Nicotine Patch: A Systematic Review. Experimental And Clinical Psychopharmacology 2014, 22: 373-383. PMID: 25133506, PMCID: PMC4180800, DOI: 10.1037/a0037692.Peer-Reviewed Original ResearchMeSH KeywordsClinical Trials as TopicFemaleHumansMaleSex CharacteristicsSmokingTobacco Use Cessation DevicesConceptsTransdermal nicotine patchNicotine patchCessation outcomesClinical trialsSmoking cessationSmoking cessation treatmentMenstrual cycle phaseCessation treatmentSex-related variablesInclusion criteriaMEDLINE searchSmoking treatmentSide effectsBetter outcomesTreatment efficacyConsideration of sexSystematic reviewPotential articlesInclusion of sexSkin irritationMore womenTrialsOutcomesSexWomen
2008
A brief 7-day estimate of alcohol consumption for use in smoking cessation clinical trials
Toll BA, Leeman RF, McKee SA, O'Malley SS. A brief 7-day estimate of alcohol consumption for use in smoking cessation clinical trials. Addictive Behaviors 2008, 33: 1606-1609. PMID: 18722721, PMCID: PMC2577001, DOI: 10.1016/j.addbeh.2008.07.007.Peer-Reviewed Original ResearchMeSH KeywordsAdultAlcohol DrinkingClinical Trials as TopicEvidence-Based MedicineFemaleHumansMaleMiddle AgedSecondary PreventionSmokingSmoking CessationTime FactorsConceptsCessation clinical trialHeavy drinking daysNumber of drinksClinical trialsDays abstinentDrinking daysTimeline FollowbackSmoking cessation clinical trialAlcohol useTreatment periodSmoking relapseAlcohol consumptionCessation studyTotal abstinenceBaselineDrinking dataTime burdenAbstinentAbstinenceTrialsDaysTreatmentMost studiesLong periodLonger time window